This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell 18.81 points to 877.55 Thursday, another disappointing day for the junior exchange. Since the start of September, the TSX-V has gone up for only three of the 23 trading days. Why wait for the end of the year to take your losses when your stocks are so cheap today? Today's decline marks a new one-year low for the TSX-V Index, which is quickly approaching the 859.31 low reached in June, 2013. Should the exchange fall lower than 859.31, the next level of resistance is 678.62, the bottom of the market crash in 2008.

John O'Sullivan and Donald Wright's capital pool shell, Cinaport Acquisition Corp., completed its qualifying transaction yesterday by acquiring a licensed producer of medical marijuana, Mettrum Ltd. The shell rolled back 1:14.5625 and issued 33,256,880 postconsolidated shares to the shareholders of Mettrum. Today the company resumed trading under the name Mettrum Health Corp. (MT). It was a disappointing first day for many Mettrum shareholders, with the stock opening at $1.50, rising to $2.08 and then closing at $1.99 on 268,100 shares. About two-fifths of the company's shareholders are already down one-fifth on their investment. Before listing, the medical marijuana producer sold 13.8 million subscription receipts at $2.50 each for $34.5-million. Those receipts converted into units of Mettrum Health, comprising one share and one warrant, exercisable at $3.50 for one year. The IPO shareholders of Cinaport are doing much better. They paid 10 cents for their shares before the shell went public in November, 2011. Adjusting for the 1:14.5625 rollback, Cinaport shareholders could have sold at today's closing price for a profit of 36 per cent.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS